Close Menu

NEW YORK (GenomeWeb) – MDxHealth today announced a partnership with SouthGenetics to market its ConfirmMDx test for prostate cancer in Latin America.

Under the terms of the agreement, Montevideo, Uruguay-based SouthGenetics secures rights to commercialize ConfirmMDx for Prostate Cancer in Argentina, Bolivia, Chile, Colombia, the Dominican Republic, Ecuador, Mexico, Peru, Panama, Paraguay, Uruguay, and Venezuela. Financial and other details of the agreement were not disclosed.

All tests will be processed at MDxHealth's CLIA-certified laboratory in Irvine, California.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports that genomics is being applied to trace and try to prevent additional COVID-19 waves.

Rady's Children Hospital and San Diego County are teaming up to test pediatric patients and their families for COVID-19 to gauge the spread of the virus locally, according to the San Diego Union-Tribune.

Wildlife managers aim to boost the genetic diversity of Mexican gray wolves by placing captive-born foster pups into packs with similarly aged wild pups, the Mercury News reports.

In Science this week: Genetic Probability tool identifies likely diagnoses in 45 percent of inflammatory arthritis cases, and more.